Cleft Palate in a Rare Case of Variant Klinefelter Syndrome with 48,XXXY/46,XY Mosaicism

2009 ◽  
Vol 46 (5) ◽  
pp. 555-557 ◽  
Author(s):  
Mina Hur ◽  
Hyoun Chan Cho ◽  
Kyu Man Lee ◽  
Hyokhan Park ◽  
So Yeon Lee ◽  
...  

Variant Klinefelter syndrome with 48,XXXY/46,XY mosaicism has been rarely reported, and its phenotypic features, compared with those of the classic type, have not been well delineated. We describe a newborn baby with phenotypic abnormalities, including cleft palate and low-set ears. The cytogenetic analysis of peripheral blood lymphocytes showed a karyotype of 48,XXXY[36]/46,XY[4]. To the best of our knowledge, this is the first case in which 48,XXXY/46,XY mosaicism was related to the congenital anomaly of cleft palate. This case underscores that cytogenetic analysis should be a mandatory workup for the patient with cleft palate and that cleft palate may be a rare clinical presentation of the variant Klinefelter syndrome.

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 1896-1896
Author(s):  
Duck Cho ◽  
Mark H. Yazer ◽  
Myung-Geun Shin ◽  
Jong-Hee Shin ◽  
Soon-Pal Suh ◽  
...  

Abstract A chimera is an organism whose DNA is derived from multiple zygotes whereas a mosaic individual’s DNA is entirely derived from a single zygote. We report a case of a chimera who also had cytogenetic features of mosaicism. A 39-year old father of one child, healthy, morphologically normal Korean male with apparent B3 blood group was identified at the time of blood donation. On forward typing 50% of his RBCs were strongly agglutinated by monoclonal anti-B in the manual tube method. The remaining RBCs were type O. Reverse typing revealed a strong anti-A. Complete ABO exon and flanking intronic region sequencing unexpectedly revealed an O01/O02 genotype. He had never been transfused nor received a BMT, and denied having a twin. Chimerism or mosaicism was suspected so additional specimens were collected from the propositus and his parents. Extended RBC phenotyping of the propositus by the gel card technique using monoclonal reagents revealed mixed field agglutination in the M, Kpb, Lub and Jka antigens. B allele haplotype-specific PCR, and exon 6 and 7 cloning and sequencing performed on genomic DNA from the propositus revealed a third ABO allele, B101. Sequencing of exons 6 and 7 and flanking intronic regions of his parents’ ABO alleles revealed a B101 allele in both parents along with an O01 allele (maternal) and an O02 allele (paternal). A total of 9 STR loci were analyzed on DNA extracted from blood, buccal swabs and hair from the propositus and on DNA isolated from peripheral blood lymphocytes from both his parents. Four loci demonstrated a pattern consistent with a double paternal DNA contribution, thus confirming the presence of chimerism (Table 1). Sequence-based typing of HLA class I and II loci was performed on DNA from peripheral blood lymphocytes from these 3 family members but revealed only a single allelic contribution from both parents in the propositus. The propositus’ karyotype revealed a mosaic pattern with 32/50 metaphases demonstrating 46, XY and 18/50 metaphases demonstrating 47, XYY. Overall, an extra paternal set of DNA markers was demonstrable by STR analysis in tissues arising from different germ layers. The propositus is thus a dispermic chimera most likely resulting from parthenogenetic division of the ovum and its subsequent fertilization by two spermatozoa: one with a 23, Y DNA complement and the second with a different 24, YY complement. This would explain the apparent single maternal DNA contribution. Alternatively a non-dysjunction event producing the mosaic 47, XYY karyotype could have occurred after fertilization. Given the mixed field blood group his ABO genotype is most likely B101/O01 and O01/O02. Consistent with other cases of mosaic 47, XYY syndrome our propositus is healthy, morphologically normal and fertile. This is the first case of a dispermic chimera with mosaic 47, XYY syndrome detected at the time of blood donation. STR results demonstrating a double paternal DNA contribution in disparate tissues DNA polymorphism Father Mother Propositus (blood) Propositus (buccal swab) Propositus (hair) D3S1358 15,16 16,17 15,16,17 15,16,17 15,16,17 D5S818 10,12 9,13 10,12,13 10,12,13 10,12,13 D13S317 12,14 8,9 9,12,14 9,12,14 9,12,14 D18S51 16,19 14,15 15,16,19 15,16,19 15,16,19


2005 ◽  
Vol 11 (2) ◽  
pp. 107-112 ◽  
Author(s):  
R. Bunkova ◽  
I. Marova ◽  
Z. Pokorna ◽  
A. Lojek

This work was focused on comparison of antimutagenic effect of selected plant extracts (carrot, paprika, tomato, spinach, onion, kiwi and green tea) analysed by two independent tests of genotoxicity: i) the Ames test with Salmonella typhimurium TA98 and ii) cytogenetic analysis of peripheral blood lymphocytes (CAPL). Both methods were proved without and/or with metabolic activation. Samples were allowed to be positive antimutagens based on their ability to inhibit the mutagenic effects of standard mutagens. High positive results (more than 60% of inhibition of mutagenic effect) were obtained with extract from green tea. Extracts from paprika, carrot and spinach as well as solutions of standard alltrans-carotene and some standard flavonoids showed antimutagenic (40-60% of inhibition) or weakly antimutagenic (20-40% of inhibition) effects. Positive antimutagenic effects of extracts from spinach and green tea were determined using CAPL method too. Further, the comparison of antimutagenic activity and antioxidant capacity of tested samples analysed using TRAP (total radical-trapping antioxidant parameter) method was proved. Extract from green tea showed the highest antioxidant as well as antimutagenic capacity, but no correlation was found between these parameters in all tested extracts.


2020 ◽  
Vol 66 (2) ◽  
pp. 33-41
Author(s):  
Margarita A. Dudina ◽  
Andrey Savchenko ◽  
Sergey A. Dogadin ◽  
Ivan I. Gvozdev

BACKGROUND: The regulatory effect of thyroid hormones on the metabolism of the immune system cells (activation of oxidative processes, separation of oxidative phosphorylation and increased protein synthesis) depends on their number. Changes in the activity of intracellular enzymes in Graves disease (GD) can determine the mechanisms of maintaining autoimmune inflammation in relapse of the disease. The exact role of NAD(P)-dependent dehydrogenases in the development and maintenance of immune response in GD is still poorly investigated. AIMS: To study the activity of NAD(P)-dependent dehydrogenases in lymphocytes of peripheral blood in patients with manifestation and relapse of GD to clarify the mechanisms of development and progression of the autoimmune process. METHODS: A single-center, cohort, prospective, continuous, observational, open-label, controlled trial was conducted to evaluate the lymphocytes NAD(P)-dependent activity in 151 women with GD and hyperthyroidism, mean age 40.713.2, 52 (37.14%), who were on follow-up at the endocrinology center of Krasnoyarsk Regional clinical hospital from 2016 to 2019. The NAD(P)-dependent dehydrogenases activity measured using biochemiluminescence method. RESULTS: In patients with newly diagnosed of GD, relative to the control values and levels detected in relapse group we observe the increase of G6PDH and decrease of NADH-LDH. In GD relapse group compare to the control range in blood lymphocytes decreases the activity of LDH and NAD(P)-ICDH. In patients with newly diagnosed GD, two positive сorrelation were found: between fT3 level and MDG activity (r=0.90, p=0.037), and between fT4 level and NAD(P)-ICDH activity (r=0.82, p=0.007). In patients with relapse of GD positive relationships between the concentration of TSH and the activity of LDH (r=0.73, p=0.039), and MDH (r=0.93, p=0.002), as well as in a pair of fT4 and NADGDH (r=0.70, p=0.036) were revealed. CONCLUSION: The established differences in the activity of NAD(P)-dependent dehydrogenases in peripheral blood lymphocytes in patients with manifestation and relapse of GD can reflect in the first case the response of immune cells to a functional-regulatory signal with the development of hyperthyroidism, and in the second case, adaptive changes with the progression of autoimmune process.


Sign in / Sign up

Export Citation Format

Share Document